Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1624326 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $5.10Day −5.20%Mkt cap $37M1Y −70.8%Off 52W high −82.1%Vol (1Y) 132.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,509 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.4% of sh out |
| Days to cover2.2d |
| 13F net flow (QoQ)−17.49% |
| Top-10 13F concentration99.9% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$85,000 |
| Earnings (TTM)-$18.6M |
| Net margin564.8% |
| ROIC−274.7% |
| Sales growth 3Y−42.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−23.0% |
| 1Y−70.8% |
| 3Y−97.0% |
| 5Y−99.8% |
| 10Y−99.9% |
| Since incept. (ann.)−50.6% |
Total return through 2026-07-29 · series begins 2016-07-28. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)132.4% |
| Ann. volatility (3Y)119.5% |
| Sharpe (1Y)−0.41 |
| Sharpe (3Y)−0.45 |
| Max drawdown (1Y)−75.1% |
| Max drawdown (3Y)−98.1% |
| Beta (3Y vs SPY)−0.15 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Two Seas Capital LP | 461,539 | $5M | 6.35% | new |
| FIRST MANHATTAN CO. LLC. | 23,805 | $241,621 | 0.33% | −96.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 11,777 | $119,544 | 0.16% | −93.0% |
| Byrne Asset Management LLC | 6,420 | $65,163 | 0.09% | −94.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,917 | $60,058 | 0.08% | new |
| VANGUARD FIDUCIARY TRUST CO | 5,429 | $55,104 | 0.07% | new |
| BlackRock, Inc. | 2,416 | $24,522 | 0.03% | −96.7% |
| Tower Research Capital LLC (TRC) | 622 | $6,313 | 0.01% | −85.8% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$4.42 | — | $22,000 | +175.0% |
| 2025-12-31 | 2026-03-27 | — | — | $52,000 | — |
| 2025-09-30 | 2025-11-12 | — | — | $5,000 | −99.5% |
| 2025-06-30 | 2025-08-14 | — | — | $6,000 | −99.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
